These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 33533172)

  • 1. Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis.
    Zhang Z; Gao Q; Wang S
    J Cell Mol Med; 2021 Mar; 25(5):2655-2665. PubMed ID: 33533172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis.
    Yue C; Chen J; Li Z; Li L; Chen J; Guo Y
    J Exp Clin Cancer Res; 2020 Nov; 39(1):240. PubMed ID: 33183350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
    Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.
    Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H
    Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
    Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
    J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic Glioma Stem Cell-Derived Exosomes Containing Linc01060 Promote Progression of Glioma by Regulating the MZF1/c-Myc/HIF1α Axis.
    Li J; Liao T; Liu H; Yuan H; Ouyang T; Wang J; Chai S; Li J; Chen J; Li X; Zhao H; Xiong N
    Cancer Res; 2021 Jan; 81(1):114-128. PubMed ID: 33158815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7.
    Jung JH; Jung DB; Kim H; Lee H; Kang SE; Srivastava SK; Yun M; Kim SH
    Oncogene; 2018 Jul; 37(27):3715-3728. PubMed ID: 29628506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis.
    Ruan DY; Li T; Wang YN; Meng Q; Li Y; Yu K; Wang M; Lin JF; Luo LZ; Wang DS; Lin JZ; Bai L; Liu ZX; Zhao Q; Wu XY; Ju HQ; Xu RH
    Oncogene; 2021 Aug; 40(33):5168-5181. PubMed ID: 34218271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis.
    Lin Z; Wan AH; Sun L; Liang H; Niu Y; Deng Y; Yan S; Wang QP; Bu X; Zhang X; Hu K; Wan G; He W
    Mol Ther; 2023 Feb; 31(2):517-534. PubMed ID: 36307991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTO-mediated ZNF687 accelerates tumor growth, metastasis, and angiogenesis in colorectal cancer through the Wnt/β-catenin pathway.
    Li J; Li S; Xing X; Liu N; Lai S; Liao D; Li J
    Biotechnol Appl Biochem; 2024 Apr; 71(2):245-255. PubMed ID: 37983718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer.
    Mudduluru G; Vajkoczy P; Allgayer H
    Mol Cancer Res; 2010 Feb; 8(2):159-69. PubMed ID: 20145042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer.
    Sato K; Masuda T; Hu Q; Tobo T; Gillaspie S; Niida A; Thornton M; Kuroda Y; Eguchi H; Nakagawa T; Asano K; Mimori K
    EBioMedicine; 2019 Jun; 44():387-402. PubMed ID: 31175057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
    Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
    Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-6125 promotes colorectal cancer growth through YTHDF2-dependent recognition of N6-methyladenosine-modified GSK3β.
    Li H; Zhang N; Jiao X; Wang C; Sun W; He Y; Ren G; Huang S; Li M; Chang Y; Jin Z; Xie Q; Zhang X; Huang H; Jin H
    Clin Transl Med; 2021 Oct; 11(10):e602. PubMed ID: 34709763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis.
    Zhuang C; Zhuang C; Luo X; Huang X; Yao L; Li J; Li Y; Xiong T; Ye J; Zhang F; Gui Y
    J Cell Mol Med; 2019 Mar; 23(3):2163-2173. PubMed ID: 30648791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p55PIK transcriptionally activated by MZF1 promotes colorectal cancer cell proliferation.
    Deng Y; Wang J; Wang G; Jin Y; Luo X; Xia X; Gong J; Hu J
    Biomed Res Int; 2013; 2013():868131. PubMed ID: 23509792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription Factor Myeloid Zinc-Finger 1 Suppresses Human Gastric Carcinogenesis by Interacting with Metallothionein 2A.
    Lin S; Wang X; Pan Y; Tian R; Lin B; Jiang G; Chen K; He Y; Zhang L; Zhai W; Jin P; Yang L; Li G; Wu Y; Hu J; Gong W; Chang Z; Sheng JQ; Lu Y; Wang JM; Huang J
    Clin Cancer Res; 2019 Feb; 25(3):1050-1062. PubMed ID: 30301827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155/23a Cluster-MXI1 Feedback Circuit in Glioma.
    Xiao L; Li X; Mu Z; Zhou J; Zhou P; Xie C; Jiang S
    Cancer Res; 2020 Sep; 80(18):3945-3958. PubMed ID: 32680921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.